Portfolio Valuation & Prioitization

A public biopharmaceutical company with a diverse product pipeline required a comprehensive understanding of the intrinsic value of their portfolio to inform their long-range planning, evaluate potential financing opportunities, and provide a more informed and cohesive perspective for the Board of Directors and investor relations.